Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Dickstein, J. Bebchuk, J. Wittes (2012)
The high-risk myocardial infarction database initiative.Progress in cardiovascular diseases, 54 4
B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, B. Roniker, R. Bittman, Steve Hurley, J. Kleiman, M. Gatlin (2003)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.The New England journal of medicine, 348 14
H. Dargie (2001)
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trialThe Lancet, 357
Stefan Hohnloser, Jonathan Halperin, A. Camm, P. Gao, D. Radzik, S. Connolly (2014)
Interaction Between Digoxin and Dronedarone in the PALLAS TrialCirculation: Arrhythmia and Electrophysiology, 7
P. Austin, M. Mamdani (2006)
A comparison of propensity score methods: a case‐study estimating the effectiveness of post‐AMI statin useStatistics in Medicine, 25
A. Maggioni, S. Anker, U. Dahlström, G. Filippatos, P. Ponikowski, F. Zannad, O. Amir, O. Chioncel, M. Leiro, J. Drożdż, A. Erglis, E. Fazlibegović, C. Fonseca, F. Fruhwald, P. Gatzov, E. Goncalvesova, M. Hassanein, J. Hradec, A. Kavoliūnienė, M. Lainščak, D. Logeart, B. Merkely, M. Metra, H. Persson, P. Seferovic, A. Temizhan, D. Tousoulis, L. Tavazzi (2013)
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long‐Term RegistryEuropean Journal of Heart Failure, 15
J. Muller, Z. Turi, P. Stone, R. Rude, D. Raabe, A. Jaffe, H. Gold, N. Gustafson, W. Poole, E. Passamani, T. Smith, E. Braunwald (1986)
Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study.The New England journal of medicine, 314 5
P. Jabre, V. Roger, M. Murad, A. Chamberlain, L. Prokop, F. Adnet, X. Jouven (2011)
Mortality Associated With Atrial Fibrillation in Patients With Myocardial Infarction: A Systematic Review and Meta-AnalysisCirculation, 123
G. Perry, E. Brown, R. Thornton, T. Shiva, J. Hubbard, K. Reddy, J. Doherty, F. Cardello, A. Fast, M. Radford, J. Folger, G. Bhaskar, R. Zoble, Sridharan, R. Loungani, M. Gheorghiade, A. Hsieh, C. Tommaso, M. Mansuri, M. Guess, S. Akhtar, S. Wagner, K. Hagan, K. Mcintyre, P. Ruble, M. Moten, A. Riley, G. Pierpont, Anand, G. Patel, B. Puram, B. Eladasari, J. Karnegis, E. Gillie, M. Crawford, W. Graettinger, A. Shah, J. Sacco, M. Chaudhry, D. Dolen, N. Elsherif, S. BekheitSaad, E. Campos, J. Greene, Khanijo, U. Kumar, G. Mallis, S. Mookherjee, M. DibnerDunlap, S. Gupta, K. Danisa, U. Thadani, A. Tan, M. Rajachar, M. Amidi, M. Oreilly, C. Hassapoyannes, M. Davies, V. Kumar, D. Okerson, K. Ramanathan, B. Putatunda, A. Gollapudi, A. Montero, P. Mohanty, C. Lui, S. Thagirisa, R. Lee, T. Glatter, K. Bodine, D. Roberts, M. Bertoglio, G. Dennish, R. Sarma, G. Gregoratos, D. Rausch, W. Pitt, B. Kennelly, D. Fahrenholtz, R. Gordon, L. Horwitz, R. Rothbart, P. Nutting, L. Lutz, D. Copen, A. Rashkow, J. Babb, L. VanVoorhees, A. Silverman, M. Stillabower, A. Miller, H. NguyenPho, R. Safford, S. Fishman, J. Neiman, M. Stein, J. Dominguez, G. Abernathy, P. Nair, L. Goodman, T. Cook, W. Wickemeyer, D. Berkson, J. Mathew, H. Richman, D. Lubell, R. Lang, E. Zajac, R. Rosenstein, M. Silver, J. Shanes, K. Kelly, M. Pequignot, R. Campbell, P. Kirlin, D. Ziperman, D. Denny, L. Gamble, M. Weiss, P. Kaimal, R. Dhurandhar, H. Ventura, M. Godley, C. Pu, E. Schick, D. Barbour, D. Salmon, M. Goldstein, M. Effron, J. Fleg, K. Baughman, R. Weiss, K. Ericson, W. Sturrock, J. Heinsimer, G. Timmis, Shaler Smith, D. Shrestha, W. Duvernoy, J. Hickner, B. Lewis, T. OBrien, S. Yarows, H. Willens, D. Mast, T. Johnson, R. Rodeheffer, M. Siefert, L. Swenson, P. Denes, R. Gudapati, F. Charles, M. Rich, Beckham, W. Hamilton, P. Abele, D. Harper, R. O'Kelly, A. Forker, F. Kahl, B. Garrou, Te Klang, K. Popio, S. Mohiuddin, E. Pollak, A. Chiaramida, J. Gregory, L. Papa, J. Abrams, S. Ung, C. Jutila, R. Croke, S. Chiaramida, R. Lucariello, D. Rim, M. Goldberger, R. Kohn, S. Graham, E. Philbin, K. Sheesley, A. Nafziger, G. Macina, J. Hsueh, S. Zoneraich, A. Binder, C. Weinstein, J. Morrison, A. Cameron, E. Vanderbush, J. Brown, P. Pande, E. Lader, R. Kay, D. Bloomfield, T. Costantino, D. Heiselman, S. Radwany, Smith, R. Hobbs, T. Fraker, T. Frerking, A. Deleon, L. Christie, M. Toren, J. Grover, F. McBarron, D. Harris, R. McLean, L. Morris, J. Zatuchni, J. Boehmer, B. Clemson, H. Lipshutz, R. Small, R. Ufret, Je LugoRodriquez, A. Khan, M. Yousefian, G. Friesinger, D. Ely, J. Farmer, J. Young, R. Payne, R. Fowles, A. Lee, Y. Shalev, Albitar, G. Schroeder, L. Radant, T. Hankey, S. Rezkalla, D. Groden, K. Teo, D. Humen, D. Wong, P. Greenwood, T. Talibi, W. Hui, W. Klinke, M. Senaratne, M. Goeres, D. Hughes, M. Sayeed, D. Roth, Belenkie, D. Manyari, K. Borgersen, L. Read, D. Kinloch, R. Reid, N. Barber, B. Horner, G. Kenefick, R. Kuritzky, Imrie, K. Wagner, S. Rabkin, H. Mizgala, L. Tarry, A. Dodek, J. Kornder, T. Ashton, D. Barr, J. Dufton, R. Sweeny, A. Morris, R. Bessoudo, D. Marr, Milton, B. Thompson, Robinson, B. Sussex, M. Tobin, D. McMahon, D. Folkins, R. Crowell, L. Lalonde, C. Koilpillai, R. Hatheway, M. Oreilly, T. Machel, Hack, J. Stewart, P. Tanser, B. Sullivan, S. Hagar, B. Quinn, R. Davies, M. Baird, W. Williams, M. Lemay, L. Higginson, M. Turek, R. Sochowski, A. Weeks, M. Jacobs, R. Baigrie, M. DeVilla, G. Vértes, B. Bożek, J. Goode, A. Ricci, J. Swan, D. Fell, S. LevinoffRoth, J. Arnold, L. Patrick, R. Southern, C. Rinne, D. Brisbin, J. Deyoung, T. Baitz, S. Vizel, J. Minkowitz, P. Letarte, Y. Chan, K. Kwok, S. Nawaz, F. Ganjavi, L. Yao, J. Misterski, D. Raco, A. Hess, G. Kuruvilla, L. Silverberg, D. Borts, J. Fulop, M. Weingert, R. Carter, B. Sahay, J. Hickey, G. Lalonde, G. Gosselin, M. Bourassa, C. Goulet, M. Joyal, M. Méthé, G. Honos, D. Fitchett, A. Serpa, F. Sestier, G. Roberge, Y. Latour, C. Rondeau, D. Gossard, J. Lenis, R. Brossoit, L. Simard, F. Delage, P. Auger, D. Saulnier, P. Talbot, J. Beaudoin, J. Campeau, G. Pruneau, M. Tamilia, G. Boutros, B. Comeau, R. Starra, R. StHilaire, J. Veilleux, M. Mercier, J. Poulin, K. Maclellan, S. Lepage, J. Rouleau, N. Bruinsma, C. Lévesque, R. Delarochelliére, M. Leblanc, S. Kouz, G. Kiwan, M. LaForest, J. Brooks, G. Bouchard, P. Gervais, J. Brophy, J. Gagnon, N. Habib, A. Basu, A. Lutterodt, M. Khouri, R. Gorlin, D. Egan, R. Garg, S. Yusuf, T. Montague, T. Smith, J. Cohn, G. Dagenais, R. Davies, D. Johnstone, C. Fye, Sather, D. Deykin, G. Francis, J. Collins, W. Williford, B. Singh (1997)
The effect of digoxin on mortality and morbidity in patients with heart failure.The New England journal of medicine, 336 8
G. Fonarow, J. Heywood, P. Heidenreich, M. Lopatin, C. Yancy (2007)
Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE).American heart journal, 153 6
M. Turakhia, P. Santangeli, W. Winkelmayer, Xiangyan Xu, Aditya Ullal, Claire Than, Susan Schmitt, T. Holmes, S. Frayne, C. Phibbs, Felix Yang, D. Hoang, P. Ho, P. Heidenreich (2014)
Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study.Journal of the American College of Cardiology, 64 7
A. Jacobs, F. Kushner, S. Ettinger, R. Guyton, Jeffrey Anderson, E. Ohman, N. Albert, E. Antman, D. Arnett, M. Bertolet, Deepak Bhatt, R. Brindis, M. Creager, D. DeMets, K. Dickersin, G. Fonarow, R. Gibbons, J. Halperin, J. Hochman, M. Koster, S. Normand, Eduardo Ortiz, E. Peterson, William Roach, R. Sacco, Sidney Smith, W. Stevenson, G. Tomaselli, C. Yancy, W. Zoghbi, J. Harold, Yulei He, P. Mangu, A. Qaseem, M. Sayre, M. Somerfield (2013)
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Circulation, 127 4
P. Ponikowski, A. Voors, S. Anker, H. Bueno, J. Cleland, Andrew Coats, V. Falk, J. González-Juanatey, V. Harjola, E. Jankowska, M. Jessup, C. Linde, P. Nihoyannopoulos, John Parissis, B. Pieske, Jillian Riley, Giuseppe Rosano, L. Ruilope, F. Ruschitzka, Frans Rutten, P. Meer (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Journal of Heart Failure, 18
E. Amsterdam, N. Wenger, R. Brindis, D. Casey, T. Ganiats, D. Holmes, A. Jaffe, H. Jneid, R. Kelly, M. Kontos, G. Levine, P. Liebson, D. Mukherjee, E. Peterson, M. Sabatine, R. Smalling, Susan Zieman (2014)
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Journal of the American College of Cardiology, 64 24
K. Dickstein, J. Kjekshus (2002)
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trialThe Lancet, 360
K. Nademanee, R. Kannan, J. Hendrickson, M. Ookhtens, I. Kay, B. Singh (1984)
Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications.Journal of the American College of Cardiology, 4 1
K. Spargias, A. Hall, S. Ball (1999)
Safety concerns about digoxin after acute myocardial infarctionThe Lancet, 354
J. Leor, U. Goldbourt, B. Rabinowitz, H. Reicher-Reiss, V. Boyko, E. Kaplinsky, S. Behar, the Group (1995)
Digoxin and increased mortality among patients recovering from acute myocardial infarction: Importance of digoxin doseCardiovascular Drugs and Therapy, 9
M. Whitbeck, R. Charnigo, P. Khairy, K. Ziada, A. Bailey, M. Zegarra, Jignesh Shah, G. Morales, Tracy Macaulay, V. Sorrell, C. Campbell, J. Gurley, P. Anaya, Hafez Nasr, R. Bai, L. Biase, D. Booth, G. Jondeau, A. Natale, D. Roy, S. Smyth, D. Moliterno, C. Elayi (2013)
Increased mortality among patients taking digoxin--analysis from the AFFIRM study.European heart journal, 34 20
G. Berton, R. Cordiano, F. Cucchini, F. Cavuto, M. Pellegrinet, P. Palatini (2009)
Atrial fibrillation during acute myocardial infarction: association with all‐cause mortality and sudden death after 7‐year of follow‐upInternational Journal of Clinical Practice, 63
ReviewTM
Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes
A. Moss, H. Davis, J. Decamilla, C. Odoroff (1981)
Digitalis‐associated Cardiac Mortality After Myocardial InfarctionCirculation, 64
J Leor, U Goldbourt, B Rabinowitz, H Reicher-Reiss, V Boyko, E Kaplinsky, S Behar (1995)
Digoxin and increased mortality among patients recovering from acute myocardial infarction: importance of digoxin dose. The SPRINT Study GroupCardiovasc Drugs Ther/Spons Int Soc Cardiovasc Pharmacother, 9
F. Angeli, G. Reboldi, M. Garofoli, E. Ramundo, C. Poltronieri, G. Mazzotta, G. Ambrosio, P. Verdecchia (2012)
Atrial Fibrillation and Mortality in Patients with Acute Myocardial Infarction: A Systematic Overview and Meta-analysisCurrent Cardiology Reports, 14
M. Roffi, C. Patrono, J. Collet, Christian Mueller, M. Valgimigli, F. Andreotti, Jeroen Bax, M. Borger, C. Brotons, Derek Chew, B. Gencer, G. Hasenfuß, K. Kjeldsen, P. Lancellotti, U. Landmesser, J. Mehilli, D. Mukherjee, R. Storey, S. Windecker (2011)
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).European heart journal, 37 3
Nileshkumar Patel, Michael Hoosien, A. Deshmukh, A. Badheka, P. Grover, Neeraj Shah, Vikas Singh, K. Mehta, A. Chothani, Ghanshyambhai Savani, S. Arora, Vipulkumar Bhalara, Nilay Patel, Dhaval Khalpada, A. Rathod, T. Vazzana, J. Lafferty, J. Viles‐Gonzalez, R. Mitrani (2013)
Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function.International journal of cardiology, 169 5
P Ponikowski, AA Voors, SD Anker, H Bueno, JG Cleland, AJ Coats, V Falk, JR Gonzalez-Juanatey, VP Harjola, EA Jankowska, M Jessup, C Linde, P Nihoyannopoulos, JT Parissis, B Pieske, JP Riley, GM Rosano, LM Ruilope, F Ruschitzka, FH Rutten, P Meer (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESCEur Heart J, 37
K Dickstein, J Kjekshus (2002)
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist LosartanLancet, 360
B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, B. Roniker, R. Bittman, Steve Hurley, J. Kleiman, M. Gatlin (2003)
EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION, 348
J. Lynch, B. Lucchesi (1988)
Effect of digoxin on the extent of injury and the severity of arrhythmias during acute myocardial ischemia and infarction in the dog.Journal of cardiovascular pharmacology, 11 2
P. Steg, Stefan James, D. Atar, Luigi Badano, C. Blömstrom-Lundqvist, M. Borger, Carlo Mario, Kenneth Dickstein, Gregory Ducrocq, Francisco Fernández-Avilés, A. Gershlick, Pantaleo Giannuzzi, S. Halvorsen, Kurt Huber, Peter Juni, Adnan Kastrati, Juhani Knuuti, Mattie Lenzen, K. Mahaffey, M. Valgimigli, Arnoud Hof, Petr Widimsky, D. Zahger (2012)
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.European heart journal, 33 20
Y. Iesaka, K. Aonuma, A. Gosselin, T. Pinakatt, W. Stanford, J. Benson, R. Sampsell, J. Rozanski, J. Lister (1983)
Susceptibility of infarcted canine hearts to digitalis-toxic ventricular tachycardia.Journal of the American College of Cardiology, 2 1
A. Camm, P. Kirchhof, G. Lip, U. Schotten, I. Savelieva, S. Ernst, I. Gelder, N. Al-Attar, G. Hindricks, B. Prendergast, H. Heidbuchel, O. Alfieri, A. Angelini, D. Atar, P. Colonna, R. Caterina, J. Sutter, A. Goette, B. Gorenek, M. Heldal, Stefan Hohloser, P. Kolh, J. Heuzey, P. Ponikowski, F. Rutten (2010)
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).European heart journal, 31 19
S. Yusuf, J. Healey, J. Pogue, S. Chrolavicius, M. Flather, R. Hart, S. Hohnloser, C. Joyner, M. Pfeffer, S. Connolly (2011)
Irbesartan in patients with atrial fibrillation.The New England journal of medicine, 364 10
A. Moss, J. Bigger, E. Carleen, J. Fleiss, C. Odoroff, L. Rolnitzky, T. Therneau (1987)
The mortality risk associated with digitalis treatment after myocardial infarctionCardiovascular Drugs and Therapy, 1
F. Marcus (1985)
Pharmacokinetic interactions between digoxin and other drugs.Journal of the American College of Cardiology, 5 5 Suppl A
E. Antman, D. Anbe, P. Armstrong, Eric Bates, L. Green, M. Hand, J. Hochman, H. Krumholz, F. Kushner, G. Lamas, C. Mullany, J. Ornato, D. Pearle, M. Sloan, Sidney Smith (2004)
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients WiThe Canadian journal of cardiology, 20 10
J. Garcia-Rubira, Manuel Calvo-Taracido, Francisca Francisco-Aparicio, M. Almendro-Delia, A. Recio-Mayoral, A. Toral, Ó. Aramburu-Bodas, P. Vinuesa, J. Fernández, Á. Alcántara, R. Hidalgo-Urbano (2014)
The previous use of digoxin does not worsen early outcome of acute coronary syndromes: an analysis of the ARIAM RegistryInternal and Emergency Medicine, 9
M. Gheorghiade, G. Fonarow, D. Veldhuisen, J. Cleland, J. Butler, A. Epstein, Kanan Patel, I. Aban, W. Aronow, S. Anker, A. Ahmed (2013)
Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.European heart journal, 34 20
JB Washam, SR Stevens, Y Lokhnygina, JL Halperin, G Breithardt, DE Singer, KW Mahaffey, GJ Hankey, SD Berkowitz, CC Nessel, KA Fox, RM Califf, JP Piccini, MR Patel (2015)
Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)Lancet, 385
U. Bavendiek, L. Dávila, A. Koch, J. Bauersachs (2017)
Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failureEuropean Heart Journal, 38
M. Brookhart, R. Wyss, J. Layton, T. Stürmer (2013)
Propensity Score Methods for Confounding Control in Nonexperimental ResearchCirculation: Cardiovascular Quality and Outcomes, 6
D. Roy, M. Talajic, Stanley Nattel, D. Wyse, P. Dorian, Kerry Lee, M. Bourassa, J. Arnold, Alfred Buxton, A. Camm, S. Connolly, M. Dubuc, A. Ducharme, P. Guerra, Stefan Hohnloser, Jean Lambert, J. Heuzey, Gilles O'Hara, Ole Pedersen, Jean Rouleau, Bramah Singh, L. Stevenson, William Stevenson, Bernard Thibault, Albert Waldo (2008)
Rhythm control versus rate control for atrial fibrillation and heart failure.The New England journal of medicine, 358 25
M. Pfeffer, J. McMurray, E. Velazquez, J. Rouleau, L. Køber, A. Maggioni, S. Solomon, K. Swedberg, F. Werf, H. White, J. Leimberger, M. Henis, Susan Edwards, S. Zelenkofske, M. Sellers, R. Califf (2003)
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.The New England journal of medicine, 349 20
Clin Res Cardiol (2017) 106:722–733 DOI 10.1007/s00392-017-1116-z ORIGINAL PAPER Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database Initiative 1,2,3 1,2 1,2 4 • • • • Stefano Coiro Nicolas Girerd Patrick Rossignol Johann Bauersachs 5 1,2 3 6 • • • • Bertram Pitt Renaud Fay Giuseppe Ambrosio Scott D. Solomon 7 1,2 Kenneth Dickstein Faiez Zannad Received: 16 October 2016 / Accepted: 11 April 2017 / Published online: 28 April 2017 Springer-Verlag Berlin Heidelberg 2017 Abstract digitalis and 24,580 without) with the rate of all-cause Background Contradictory findings have been reported death, sudden cardiac death, cardiovascular death, HF regarding the safety and efficacy of digitalis in patients hospitalization and the combination of the latter two, over a recovering from acute myocardial infarction (MI). We mean follow-up time of 2.7 years. Patients with and studied the association of digitalis use with long-term and without atrial fibrillation (AF) were studied separately. short-term prognosis in patients presenting with an acute After a propensity score-based analysis, among patients MI complicated with heart failure (HF), left ventricular without AF, those receiving digitalis experienced
Zeitschrift für Kardiologie – Springer Journals
Published: Apr 28, 2017
Access the full text.
Sign up today, get DeepDyve free for 14 days.